New! Sign up for our free email newsletter.
Science News
from research organizations

Scientists find molecule to starve lung cancer and improve ventilator recovery

Date:
July 6, 2012
Source:
Federation of American Societies for Experimental Biology
Summary:
New research reveals a connection between sugar, cancer, and dependence on breathing machines -- microRNA-320a. Scientists show microRNA-320a as responsible for aiding glycolysis. Glycolysis, the process of converting sugar into energy, fuels some cancers and contributes to the wasting of unused muscles when people are using ventilators. Identifying ways to use microRNA-320a to starve tumors and keep unused muscles strong represents a therapeutic leap for numerous health conditions.
Share:
FULL STORY

A new research report published online in the FASEB Journal reveals a connection among sugar, cancer, and dependence on breathing machines--microRNA-320a. In the report, Stanford scientists show that the molecule microRNA-320a is responsible for helping control glycolysis. Glycolysis is the process of converting sugar into energy, which fuels the growth of some cancers, and contributes to the wasting of unused muscles such as the diaphragm when people are using ventilators. Identifying ways to use microRNA-320a to starve tumors and keep unused muscles strong would represent a significant therapeutic leap for numerous diseases and health conditions.

"We hope that this discovery will yield a new avenue of molecular treatment for cancers, particularly lung cancer, which is the number one cause of cancer deaths worldwide," said Joseph B. Shrager, M.D., a researcher involved in the work who is a Professor of Cardiothoracic Surgery, and Chief of the Division of Thoracic Surgery at Stanford University School of Medicine, and VA Palo Alto Healthcare System in California. "We also hope it can lead to a treatment to be given to intensive care unit patients who require the breathing machine, reducing the length of time they require the machine, and thereby reducing complications and deaths."

To make this discovery, Shrager and colleagues studied lung cancer tissues from patients and tissue from the diaphragm (the primary muscle used for breathing) from patients who had been on a breathing machine for more than a few hours. They found that both types of tissue had increases in glycolysis, as well as reductions in a molecule that controls glycolysis -- microRNA-320a. Test tube experiments then showed that microRNA-320a definitely controls how much energy these two very different tissues have available to them.

"Just as the discovery of angiogenesis opened new doors to find ways to stop cancers and to help the body heal itself," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal, "this discovery, on a smaller scale, does the same by identifying an important molecule that may help starve tumors and help the body recover."


Story Source:

Materials provided by Federation of American Societies for Experimental Biology. Note: Content may be edited for style and length.


Journal Reference:

  1. H. Tang, M. Lee, O. Sharpe, L. Salamone, E. J. Noonan, C. D. Hoang, S. Levine, W. H. Robinson, J. B. Shrager. Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems. The FASEB Journal, 2012; DOI: 10.1096/fj.11-197467

Cite This Page:

Federation of American Societies for Experimental Biology. "Scientists find molecule to starve lung cancer and improve ventilator recovery." ScienceDaily. ScienceDaily, 6 July 2012. <www.sciencedaily.com/releases/2012/07/120706164332.htm>.
Federation of American Societies for Experimental Biology. (2012, July 6). Scientists find molecule to starve lung cancer and improve ventilator recovery. ScienceDaily. Retrieved May 10, 2024 from www.sciencedaily.com/releases/2012/07/120706164332.htm
Federation of American Societies for Experimental Biology. "Scientists find molecule to starve lung cancer and improve ventilator recovery." ScienceDaily. www.sciencedaily.com/releases/2012/07/120706164332.htm (accessed May 10, 2024).

Explore More

from ScienceDaily

RELATED STORIES